Brief: PolyPid Clears Israeli Health Ministry GMP Inspection, Nears Commercial Manufacturing for D-PLEX
16/09/2025 14:27
Sept 16 (Reuters) - PolyPid Ltd PYPD.O: POLYPID SUCCESSFULLY COMPLETES ISRAELI MINISTRY OF HEALTH GMP INSPECTION, ADVANCING TOWARDS COMMERCIAL MANUFACTURING READINESS FOR D-PLEX₁₀₀ Source text: [ID:n0001213900-25-087942] Further company coverage: PYPD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Polypid
See all newsPolyPid Ltd reports results for the quarter ended June 30 - Earnings Summary
PolyPid Ltd expected to post a loss of 38 cents a share - Earnings Preview
Brief: Polypid Announces FDA Acceptance Of NDA With Priority Review For D-Plex₁₀₀
PolyPid, Azurity sign surgical site infection drug deal
Brief: Polypid Initiates D-Plex₁₀₀ NDA Submission To The FDA